相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
4°C, sealed storage, away from moisture
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- 规格:
10 mM * 1 mL/5 mg/10 mg/25 mg/50 mg/100 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥720.0 |
|---|---|---|---|
| 规格: | 5 mg | 产品价格: | ¥650.0 |
| 规格: | 10 mg | 产品价格: | ¥1050.0 |
| 规格: | 25 mg | 产品价格: | ¥1800.0 |
| 规格: | 50 mg | 产品价格: | ¥2700.0 |
| 规格: | 100 mg | 产品价格: | ¥4000.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
PF-04217903 mesylate
CAS No. : 956906-93-7
MCE 国际站:PF-04217903 mesylate
产品活性:PF-04217903 mesylate 是一种高效的ATP竞争性 c-Met 激酶抑制剂,Ki 为 4.8 nM。PF-04217903 mesylate 相对于 208 个激酶显示出 1000 倍以上的选择性。具有抗血管生成特性。
研究领域:Protein Tyrosine Kinase/RTK
作用靶点:c-Met/HGFR
In Vitro: PF-04217903 mesylate (0.1-10000 nM; 48-72 hours) inhibits proliferation of c-Met–amplified human GTL-16 gastric carcinoma and H1993 NSCLC cells with IC50 values of 12 and 30 nM, respectively.
PF-04217903 mesylate induces apoptosis of GTL-16 cells (IC50=31 nM) .
PF-04217903 mesylate also inhibits HGF-mediated cell migration and Matrigel invasion in several c-Met–overexpressing tumor cell lines such as human NCI-H441 lung carcinoma and HT29 colon carcinoma with IC50 values comparable with those for inhibition of c-Met phosphorylation in these cell lines (IC50= 7-12.5 nM).
PF-04217903 mesylate displays similar potency to inhibit the activity of c-Met-H1094R, c-Met-R988C, and c-Met-T1010I with IC50 of 3.1 nM, 6.4 nM, and 6.7 nM, respectively, but has no inhibitory activity against c-Met-Y1230C with IC50 of >10 μM.
In Vivo: PF-04217903 mesylate (1-30 mg/kg; p.o.; daily for 16 days) shows dose-dependent tumor growth inhibition, which correlated with the inhibition in c-Met phosphorylation in these tumors .
PF-04217903 mesylate (5-50 mg/kg, p.o.; once daily for 3 days) dose dependently inhibits c-Met, Gab-1, Erk1/2, and AKT phosphorylation and induced apoptosis (cleaved caspase-3) in U87MG xenograft tumors at all dose levels. PF-04217903 mesylate shows a significant dose-dependent reduction of human IL-8 levels in both the U87MG and GTL-16 models and decreases human VEGFA levels in the GTL-16 model. PF-04217903 mesylate strongly induces phospho-PDGFRβ levels in U87MG xenograft tumors.
相关产品:Clinical Compound Library Plus | Bioactive Compound Library Plus | Kinase Inhibitor Library | Protein Tyrosine Kinase Compound Library | Anti-Cancer Compound Library | Clinical Compound Library | Anti-Lung Cancer Compound Library | Angiogenesis-Related Compound Library | Anti-Liver Cancer Compound Library | Anti-Colorectal Cancer Compound Library | Cancer Stem Cells Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Cytokine Inhibitors Library | Afatinib | Cabozantinib | Crizotinib | Capmatinib | Foretinib | Savolitinib | Tivantinib | Merestinib | PHA-665752 | BMS 777607 | SU11274 | JNJ-38877605 | Glesatinib hydrochloride | Golvatinib | Terevalefim | Amuvatinib | Ensartinib dihydrochloride | Altiratinib | Zanzalintinib | SRI 31215 TFA | Glumetinib | AMG-337 | SGX-523 | Bozitinib | Elzovantinib | MK-2461 | PF-04217903 | SCR-1481B1
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验字(0x93)。读取坐标值的C程序如下: intTouch_GetXY() {…… for(i=;i {rPDATG|=0x40;/*DCLK为高*/ temp=(rPDATF>>7); temp&=0x1;/*通过PF7逐位读取坐标值*/ data|=temp Delay(220);/*delay220ns*/ rPDATG&=0xBF;/*DCLK为低*/ Delay(220
1SuoAc5J/PF6yv1GcZlVMply2VVbnZwH+h5RBi6lJV3Lzqkxbh7VMEMel0SptZS0vOZcrls1ZX/j0ixO2tbZbJ5iR/3rp27LCW1lYvD4Jer0hIJSUvZGDz4C8D7Kn+WQkxUNPdBNljxT8RgT2CQKqpsEdyjplGBCICEYGIQETgAEOgLqJYrvRbsVgQ0UuLZDZESgvOHR0KhlyIpEJFJBbNLZrTtmKLNKcJEeZaX3/ZMvmciCq
/tVLxTCiLlhaKFimCJ0+fxlMz9W4Le5J9e/fizJkzEmN/P39oammiRImSaNO2DXr26pX+PW3IZdfj/Su8/eKFYE0dGBQ1gUEOcTTDhQmkPgHWfKT+HqTrGcg8b8HyCIVCKtIBqg43cO1F6HJ8TYvSochj7DzohO6TSkQyPNWGfh7NiA9AFQ1koXdhVr18kRJjKUNTm36aBfsjKMxPU+q2IKqX04kUcEkLhauRO+qu93j+JQAdy4/B8cPpB6fwCrG1tcXZUydw
技术资料暂无技术资料 索取技术资料














